Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Chizbox
AddedFeb 15, 2024
UpdatedJul 2, 2026
Chizbox

Chizbox

Board Member, Cystic Fibrosis Foundation

Chizbox's Career

Cystic Fibrosis Foundation
Cystic Fibrosis Foundation

North Bethesda, MD, US

Board Member· Board
Beech Tree Labs
Beech Tree Labs

Providence, RI, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Chizbox's Career

Cystic Fibrosis Foundation
Cystic Fibrosis Foundation
NonprofitNonprofit1.3k1955North Bethesda, MD, US
Board Member· Board

Leadership at Cystic Fibrosis Foundation

Mike ThompsonMike ThompsonBoard Member
Betsy VohsBetsy VohsBoard Member
Michael BoyleMichael BoyleCEO
George PetrocheilosGeorge PetrocheilosBoard Member
Dominic CarusoDominic CarusoBoard Member
Michael MullarkeyMichael MullarkeyBoard Member
Beech Tree Labs
Beech Tree Labs
Series B$8.5M52005Providence, RI, US
Board Member· Board

Leadership at Beech Tree Labs

William J. RyanWilliam J. RyanBoard Member
John McMichaelJohn McMichaelFounder
Arthur deWitt (Terry AckermanArthur deWitt (Terry AckermanBoard Member

Similar to Beech Tree Labs

BioHealthonomicsBioHealthonomicsSanta Monica, CA, USBiotech, Pharmaceuticalsest. 1905BioHealthonomicsSanta Monica, CA, US · est. 1905

BioHealthonomics: An R&D biotech firm innovating treatments for migraines, PD, and AD.

Angel · $35.8k5
Bien-Etre LabsBien-Etre LabsHigh Point, NC, USBioactive Agentsest. 2018Bien-Etre LabsHigh Point, NC, US · est. 2018

Bien-Etre Labs: Tech-focused firm developing and marketing bioactive agents for human health.

Seed · $700k30
Brii BiosciencesBrii BiosciencesDurham, NC, USMedicines, Therapeuticsest. 2018Brii BiosciencesDurham, NC, US · est. 2018

Brii Biosciences: A US-China biotech firm innovating disease treatments for global health.

Public · $415M125
PineTree TherapeuticsPineTree TherapeuticsCambridge, MA, USBiotech Therapiesest. 2019PineTree TherapeuticsCambridge, MA, US · est. 2019

PineTree Therapeutics: Innovating biotech therapies in Oncology and Immuno-oncology.

Series B · $23.5M17

Chizbox's Similar Executives & Operators

Willix HalimWillix HalimCEO · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailJaeHong ChoiJaeHong ChoiBoard Member · KakaoMason YeoMason YeoBoard Member · Kakao

People Similar to Chizbox

Chris MarshChris MarshBoard Member · ZebelAdam HersheyAdam HersheyBoard Member · TreesJohn YangJohn YangCEO · TreezAkash OP AuroraAkash OP AuroraFounder · InfluencAnthony IacobucciAnthony IacobucciCo-Founder · Birch Tree MedicalRicky HoRicky HoCo-Founder · Treelab